Investment fund puts millions into Oncology Venture
Danish biotech company Oncology Venture has signed a deal with a European investment fund that has committed to buy new shares in the company for the sum of approximately SEK 300 million (USD 33.02 million).
Oncology Venture has entered into a financing agreement with a Luxembourg-based investment fund, which can potentially bring in the Danish biotech company up to SEK 300 million (USD 33.02 million).
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
